ALPN: Alpine Immune Sciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4,223.41
Enterprise Value ($M) 4,179.49
Book Value ($M) 327.94
Book Value / Share 5.00
Price / Book 12.88
NCAV ($M) 278.12
NCAV / Share 4.24
Price / NCAV 15.19

Profitability (mra)
Return on Invested Capital (ROIC) -0.10
Return on Assets (ROA) -0.12
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 7.86
Current Ratio 7.86

Balance Sheet (mrq) ($M)
Current Assets 330.03
Assets 379.85
Liabilities 51.91
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 58.88
Operating Income -44.25
Net Income -32.18
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -79.01
Cash from Investing -55.56
Cash from Financing 165.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-07 13G/A BlackRock Inc. 4.60 -1.05
02-14 13G/A Lynx1 Capital Management LP 6.60 22.00
02-14 13G/A Cormorant Asset Management, LP 4.39 -10.53
02-14 13G/A Paradigm Biocapital Advisors LP 5.50 37.07
02-14 13G/A Omega Fund VI, L.P. 0.00 -100.00
02-14 13G/A Ra Capital Management, L.p. 9.99 34.24
02-14 13G/A Great Point Partners Llc 6.37 1.81
12-29 13D/A Orbimed Advisors Llc 4.60 -36.58
11-22 13D/A Frazier Life Sciences VIII, L.P. 9.80 92.25
11-14 13D/A Decheng Capital China Life Sciences USD Fund III, L.P. 14.10 4.85
11-14 13D/A Alpine ImmunoSciences, L.P. 7.20 9.23

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-16 407,773 2,862,435 14.25
2024-04-15 246,754 910,875 27.09
2024-04-12 324,637 1,129,235 28.75
2024-04-11 3,031,885 5,432,528 55.81

(click for more detail)

Similar Companies
ACRV – Acrivon Therapeutics, Inc. ADMA – ADMA Biologics, Inc.
ALIM – Alimera Sciences, Inc. ALT – Altimmune, Inc.
ANIP – ANI Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io